Russell Rosenberg, PhD
from Neurology Reviews
At SLEEP 2018, Dr. Rosenberg describes phase I trials that assessed patients' driving performance, ability to be awakened, and postural stability after taking the investigational sleep–wake regulation drug lemborexant, compared with active and placebo comparators.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Neurology Reviews?
This episode is 9 minutes long.
When was this Neurology Reviews episode published?
This episode was published on September 29, 2018.
Can I download this Neurology Reviews episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.